The Adoptive Theraputic Effect of Interleukin-12 Gene Transfected Splenocytes from the Mice Immunized by Immunogene Tumor Vaccine on Implanted Liver Cancer

葛宁灵,叶胜龙,刘银坤,郑宁,孙瑞霞,汤钊猷

DOI: https://doi.org/10.3760/j.issn:1001-9030.2003.01.008

2003-01-01

Abstract:Objective To find the feasibility and antitumor effect of mIL-12 gene transfected splenocytes derived from IL-2 and B7-1 geneco-transfected liver cancer vaccines immunized mice.Methods The murine liver cancer cell strain Hepal-6 cotransfected with both human IL-2 and B7-1 gene via racombinant adenovirus vectors (200 PFU/cell)were treated with 80 mg/L mytomycin (MMC) to prepare liver cancer cell vaccines.The splenocytes isolated from the mice immunized with these vaccines were transfected with mIL-12 gene or BGFP gene or nontransfected and injected into the mice xenograft liver cancer with tumor diameter being 1 cm) respectively.The adoptive anticancer effect was investigated.Results The increasing volume of the tumor injected with mIL-12 gene transfected splenocytes intratumorally was significantly smaller than in the control groups [The increasing volume of the tume in the mIL-12 gene transfected,BGFP gene transfected,nontransfected splenocytes and saline injected groups was (0.08±0.05),(3.46±0.15),(3.56±0.23) and (8.12±0.54) cm3,respectively, P 0.05].Conclusion Significant tumor inhibitory effect was demonstrated in the immuno-activated splenocytes derived from IL-2 and B7-1 gene co-transfected liver cancer vaccines immunized mice and was further improved while modified with mIL-12 gene.It is suggested that it would be more efficiency if gene therapy,specific active immunotherapy in combination with adopive cellular immunotherapy were adopted.